VAERS reports by lot

Pfizer COVID-19 lot E19262: VAERS reports

26 VAERS reports list lot E19262 as a Pfizer COVID-19 vaccine, received between 2021-01-24 and 2024-01-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
23%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2525%
Neurological1717%
Musculoskeletal1515%
Cardiac / Cardiovascular1414%
Injection-site / Local reaction1212%
Gastrointestinal99%
Autoimmune / Immune-mediated22%
Allergic / Anaphylactic22%
Respiratory22%
Psychiatric / Neuropsychiatric22%
Thrombotic / Hematological11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
California5
Indiana2
Missouri1
New York1
Maryland1
Washington1
Georgia1
Virginia1
North Carolina1
Oregon1
Louisiana1

Reports by month received

2021-012
2021-025
2021-031
2021-041
2021-051
2021-061
2021-083
2021-092
2021-105
2021-111
2022-011
2023-051
2023-081
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.